St Louis, MONCT03492762Now EnrollingIRB Ready

Lung Inflammation Clinical Trial in St Louis, MO

Access cutting-edge lung inflammation treatment through this early phase 1 clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.

Sponsored by Washington University School of Medicine

Quick Self-Assessment

See if you qualify for this St Louis location

Preparing your pre-screening questions…

Expert Care in St Louis

Access lung inflammation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lung inflammation treatment provided free

Apply for This St Louis Location

Check if you qualify for this lung inflammation clinical trial in St Louis, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to St Louis

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit St Louis site if eligible
  4. 4Begin participation

About This Lung Inflammation Study in St Louis

The primary objective of this study is to assess the lung distribution of the Positron Emission Tomography (PET) imaging radiotracer Cu-DOTA-ECL1i, which binds to the specific population inflammatory cells, in patients with fibrotic lung diseases. This objective includes sub-studies to assess radiotracer distribution in the lung, the reproducibility of PET scans and the relationship of the scan to distribution of inflammatory cells in human lung tissue. The overall goal is to assess the potential of the radiotracer to track inflammatory cells in lung diseases.

Sponsor: Washington University School of Medicine

Who Can Participate

Inclusion Criteria

Men or women 21 years of age or older who have never smoked or current smokers who smoked at least 10 cigarettes per day (1/2 pack) and have smoked at least 100 cigarettes (5 packs) over the past month.
Screening FEV1 and FVC \> 80% of predicted
Capable of lying still and supine within the PET/CT and PET/MR scanner for \~1 hour and follow instructions for breathing protocol during the CT portion
No illicit drug use or other inhaled drug use (including pharmacologic agents, recreational agents, or illicit drugs) within the past year
No known history of cardiac, pulmonary, hepatic or renal disease or diabetes
No history of claustrophobia or other preventing condition that has previously or would interfere with completion of protocol specified imaging sessions
Able to comprehend and willing to follow instructions for the study procedures as called for by the protocol

Exclusion Criteria

Currently enrolled in another study using an investigational drug
Pregnancy (confirmed by urine pregnancy test)
Active symptoms or history of cardiac, pulmonary, hepatic or renal disease or diabetes
Currently taking any prescription medications
Presence of an implanted device that is incompatible with CT or MRI scanning
Creatinine \> 1.30 mg/dL, AST \> 50 Units/L, ALT \> 55 Units/L, or total bilirubin \> 1.2 mg/dL

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in St Louis?

Yes, this clinical trial (NCT03492762) has an active research site in St Louis, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lung Inflammation Treatment Options in St Louis, MO

If you're searching for lung inflammation treatment options in St Louis, MO, this clinical trial (NCT03492762) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our St Louis research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced lung inflammation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lung inflammation clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in St Louis, MO

See all multiple myeloma clinical trials recruiting in St Louis — not just this study.

Browse Multiple Myeloma Trials in St Louis →

Browse More Trials by Condition

Multiple Myeloma TrialsFollicular Lymphoma TrialsAll Conditions →

Ready to Join in St Louis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · St Louis, MO